trial · primary record
VIR-5500
Hormone-refractory Prostate Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 347 |
| Primary completion | 2030-06-30 |
| Primary endpoint | Part 1, 1a, 2a and Part 3: Number of Participants With Adverse Events (AEs) (mCRPC, mHSPC and BRPC) |
| Registry ID | NCT05997615 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:33.326Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05997615
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.